Search earnings tickers

ALNY

2025Q1BMO

Alnylam Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2025-05-01 · Fiscal end 2025-03-31 · Features as of 2025-04-30

← Earnings history

Street

Consensus EPS-0.37

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.6%

IV front—

P/C full—

P/C front—

Features as of2025-04-30

Run-up

Close—

Ret 5d+8.8%

Ret 10d+14.0%

Ret 20d+2.9%

Ret 30d+7.8%

Print

Actual EPS

-0.01Beat

Estimated EPS-0.37

Actual revenue

594.2M

Surprise %+97.3%

Beat / missBeat

Beat streak 42

Beat streak 82

Reaction

1-day stock reaction-0.8%

Implied vs actual

Implied 2.6%Actual 2.3%

Gap reaction-2.3%

Day result-3.1%

Next-day upNo

Realized / IV0.90×

Post tape

Post 5d+1.3%

Post 10d+11.1%

Post volume1.5M

Vol ×10d1.91×

Vol ×20d1.40×

Post range7.1%